CTSA INFRASTRUCTURE FOR AIDS RESEARCH

CTSA 艾滋病研究基础设施

基本信息

  • 批准号:
    8365156
  • 负责人:
  • 金额:
    $ 35.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. We have established the San Diego Clinical and Translational Research Institute (San Diego CTRI), with its hub located at the University of California, San Diego (UCSD). This regional center contains two universities (UCSD and San Diego State University), 4 biomedical research institutes (Salk Inst., Burnham Inst., J. Craig Venter Inst., and La Jolla Inst, for Allergy and Immunology), and 3 academic hospitals (UCSD Medical Center, VA Hospital and Rady Children's Hospital), one community health sen/ice (Palomar Pomerado Health) and 2 specialized resources~the San Diego Supercomputer Center and the California Inst, for Telecommunications and Information Technology. The CTSA program encompasses 3 health sciences professional schools (Medicine, Pharmacy, Nursing), nine clinical research PhD programs, and a Masters program in Advanced Clinical Studies. The program goals are to: 1) Provide an academic home for the discipline of clinical and translational science; 2) Establish an integrated educational pipeline to train and support clinical and translational scientists; 3) Develop a robust clinical research infrastructure that replaces silos with integrated research; 4) Enhance bioinformatics capabilities that leverage unique UCSD resources; 5) Develop novel technologies to improve research such as biomarker and imaging; 6) Form a Translational Research Alliance with research institutes and industry; 7) Form a Community Alliance with community physicians and the general public to translate scientific discoveries into best practices, increase research into health care disparities, and involve the general public in biomedical science. The CTSA program will provide the resources to develop the discipline of clinical and translational research. Through the San Diego CTRI, the educational pipeline to train the next generation of clinical and translational scientists will be enhanced. A new K12 program, an expanded K30 program, and the integration of new PhD graduate programs in clinical research highlight the proposed educational plan. The CTRI will transform education in clinical and translational science by coordinating disparate programs, providing breadth of education from high school through pre-doctoral students and providing training to post-doctoral fellows and faculty. The Institute will also transform the conduct of clinical research by providing guidance and support from initial planning through data analysis and sharing. The new structure will foster development of novel technologies to facilitate clinical research and provide support for the services and resources necessary to conduct clinical investigation. We will place special emphasis on several areas of strength such as imaging, biomarkers, community outreach, and the translation of basic science discoveries to clinical science. RELEVANCE (See instructions): The San Diego Clinical Translational Research Institute will transform the clinical research by providing guidance and support from initial planning through data analysis and sharing. It will provide an educational pipeline to train the next generation of clinical and translational scientists and involve the community in setting the direction and priorities of the organization. The Institute will foster development of novel technologies that facilitate clinical research, and provide support for the services needed to conduct clinical investigation and improve health.
该子项目是对CTSA供资的百分比的估计, 用于广泛的研究领域(艾滋病研究,儿科研究,或 临床试验)。 列出的总成本仅为CTSA金额的估算 基础设施走向这一领域的研究,而不是直接提供资金, 向子项目或子项目工作人员提供NCRR补助金。 我们已经建立了圣地亚哥临床和转化研究所(圣地亚哥CTRI),其中心位于加州大学圣地亚哥分校(UCSD)。该区域中心包括两所大学(加州大学圣地亚哥分校和圣地亚哥州立大学),4个生物医学研究所(索尔克研究所,伯纳姆研究所,J.克雷格文特尔研究所,和拉霍亚研究所,过敏和免疫学),和3个学术医院(加州大学圣地亚哥分校医疗中心,VA医院和拉迪儿童医院),一个社区卫生服务(帕洛玛Pomerado健康)和2个专业资源-圣地亚哥超级计算机中心和加州研究所,电信和信息技术。CTSA计划包括3个健康科学专业学校(医学,药学,护理),9个临床研究博士课程和一个高级临床研究硕士课程。该方案的目标是:1)为临床和转化科学学科提供学术家园; 2)建立一个综合的教育管道,以培训和支持临床和转化科学家; 3)开发一个强大的临床研究基础设施,以综合研究取代孤岛; 4)提高生物信息学能力,利用独特的UCSD资源; 5)开发新技术,以改善生物标志物和成像等研究; 6)与研究机构和行业建立转化研究联盟; 7)与社区医生和公众建立社区联盟,将科学发现转化为最佳实践,增加对医疗保健差异的研究,并让公众参与生物医学科学。CTSA计划将提供资源,以发展临床和转化研究的学科。通过圣地亚哥CTRI,培养下一代临床和转化科学家的教育管道将得到加强。一个新的K12计划,一个扩大的K30计划,以及新的博士研究生课程在临床研究中的整合突出了拟议的教育计划。CTRI将通过协调不同的项目来改变临床和转化科学的教育,提供从高中到博士前学生的广泛教育,并为博士后研究员和教师提供培训。该研究所还将通过从初始规划到数据分析和共享提供指导和支持,改变临床研究的进行方式。新架构将促进新技术的发展,以促进临床研究,并为进行临床研究所需的服务和资源提供支持。我们将特别强调几个优势领域,如成像,生物标志物,社区推广,以及基础科学发现到临床科学的翻译。相关性(参见说明):圣地亚哥临床转化研究所将通过从初始规划到数据分析和共享提供指导和支持来改变临床研究。它将提供一个教育管道,以培养下一代临床和转化科学家,并让社区参与制定该组织的方向和优先事项。该研究所将促进新技术的开发,促进临床研究,并为开展临床研究和改善健康所需的服务提供支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY S FIRESTEIN其他文献

GARY S FIRESTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY S FIRESTEIN', 18)}}的其他基金

Pathogenic role of ILC2 in rheumatoid arthritis
ILC2 在类风湿性关节炎中的致病作用
  • 批准号:
    10269026
  • 财政年份:
    2020
  • 资助金额:
    $ 35.68万
  • 项目类别:
Pathogenic role of ILC2 in rheumatoid arthritis
ILC2 在类风湿性关节炎中的致病作用
  • 批准号:
    10057498
  • 财政年份:
    2020
  • 资助金额:
    $ 35.68万
  • 项目类别:
Joint Bioinformatics and Computational Core of the MARC
MARC 联合生物信息学和计算核心
  • 批准号:
    10007639
  • 财政年份:
    2018
  • 资助金额:
    $ 35.68万
  • 项目类别:
Joint Bioinformatics and Computational Core of the MARC
MARC 联合生物信息学和计算核心
  • 批准号:
    10254254
  • 财政年份:
    2018
  • 资助金额:
    $ 35.68万
  • 项目类别:
Joint-location specific pathogenic pathways in rheumatoid arthritis
类风湿性关节炎的关节部位特异性致病途径
  • 批准号:
    10647624
  • 财政年份:
    2018
  • 资助金额:
    $ 35.68万
  • 项目类别:
Joint Bioinformatics and Computational Core of the MARC
MARC 联合生物信息学和计算核心
  • 批准号:
    10472687
  • 财政年份:
    2018
  • 资助金额:
    $ 35.68万
  • 项目类别:
Joint-location specific pathogenic pathways in rheumatoid arthritis
类风湿性关节炎的关节部位特异性致病途径
  • 批准号:
    9921295
  • 财政年份:
    2018
  • 资助金额:
    $ 35.68万
  • 项目类别:
Identifying synergistic therapeutic targets in RA using systems biology
利用系统生物学确定 RA 的协同治疗靶点
  • 批准号:
    9164023
  • 财政年份:
    2016
  • 资助金额:
    $ 35.68万
  • 项目类别:
UC San Diego Clinical and Translational Research Institute
加州大学圣地亚哥分校临床和转化研究所
  • 批准号:
    10400206
  • 财政年份:
    2015
  • 资助金额:
    $ 35.68万
  • 项目类别:
UC San Diego Clinical and Translational Research Institute
加州大学圣地亚哥分校临床和转化研究所
  • 批准号:
    10155614
  • 财政年份:
    2015
  • 资助金额:
    $ 35.68万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.68万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 35.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了